![Company](https://d2qa4785ekzzy0.cloudfront.net/typo3temp/assets/images/csm_CMN_Companies_to_Follow_2023_01_17_81d7a58868_1c503a0f51.png)
Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
ERS Genomics
Genome editing tool: CRISPR-Cas9
Funding stage: Private
Location: Dublin, Ireland
Website: https://www.sumitomo-pharma.com/
Partners: Sumitomo Pharma
![](https://d2qa4785ekzzy0.cloudfront.net/typo3temp/assets/images/csm_ers_logo_f29fed2fce_531d057733.png)
ERS Genomics is founded by Nobel prize winner Emanuelle Charpentier, and holds multiple patents to the CRISPR-Cas9 technology. The company has provided non-exclusive licenses for the use of CRISPR-Cas9 to many companies worldwide, although many remain undisclosed.